Theranostics 2024; 14(4):1631-1646. doi:10.7150/thno.92463 This issue Cite

Review

Emerging role of extracellular vesicles in diabetic retinopathy

Junyan Zhu1,2#, Jin Huang1#, Yaoxiang Sun3, Wenrong Xu1,2✉, Hui Qian2✉

1. Department of Gynecology and obstetrics, The Affiliated Yixing Hospital of Jiangsu University, 214200, China.
2. Jiangsu Province Key Laboratory of Medical Science and Laboratory Medicine, Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
3. Department of clinical laboratory, The Affiliated Yixing Hospital of Jiangsu University, Yixing, 214200, China.
# Equal Contributors.

Citation:
Zhu J, Huang J, Sun Y, Xu W, Qian H. Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics 2024; 14(4):1631-1646. doi:10.7150/thno.92463. https://www.thno.org/v14p1631.htm
Other styles

File import instruction

Abstract

Graphic abstract

Diabetic retinopathy (DR), a complex complication of diabetes mellitus (DM), is a leading cause of adult blindness. Hyperglycemia triggers DR, resulting in microvascular damage, glial apoptosis, and neuronal degeneration. Inflammation and oxidative stress play crucial roles during this process. Current clinical treatments for DR primarily target the advanced retinal disorder but offer limited benefits with inevitable side effects. Extracellular vesicles (EVs) exhibit unique morphological features, contents, and biological properties and can be found in cell culture supernatants, various body fluids, and tissues. In DR, EVs with specific cargo composition would induce the reaction of receptor cell once internalized, mediating cellular communication and disease progression. Increasing evidence indicates that monitoring changes in EV quantity and content in DR can aid in disease diagnosis and prognosis. Furthermore, extensive research is investigating the potential of these nanoparticles as effective therapeutic agents in preclinical models of DR. This review explores the current understanding of the pathological effects of EVs in DR development, discusses their potential as biomarkers and therapeutic strategies, and paves the way for further research and therapeutic advancements.

Keywords: Extracellular vesicles, Diabetic retinopathy, Pathogenesis, Diagnosis, Therapy


Citation styles

APA
Zhu, J., Huang, J., Sun, Y., Xu, W., Qian, H. (2024). Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics, 14(4), 1631-1646. https://doi.org/10.7150/thno.92463.

ACS
Zhu, J.; Huang, J.; Sun, Y.; Xu, W.; Qian, H. Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics 2024, 14 (4), 1631-1646. DOI: 10.7150/thno.92463.

NLM
Zhu J, Huang J, Sun Y, Xu W, Qian H. Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics 2024; 14(4):1631-1646. doi:10.7150/thno.92463. https://www.thno.org/v14p1631.htm

CSE
Zhu J, Huang J, Sun Y, Xu W, Qian H. 2024. Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics. 14(4):1631-1646.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image